Covalab invests more than €1 million in bioproduction operations for antibodies for Covid-19 diagnostics
Barbara IoT raises €2.5M in funding from Caixa Capital Risc and Iberdrola
AdBio partners welcomes Inserm Transfert as investor in second fund – AFB Fund II
Ribonexus receives €2M in deep tech financing from Bpifrance
CardioRenal raises €3.3 million
SeaBeLife receives close to €1.4M deep tech financing from Bpifrance
CONDOR project for precision medicine and sarcoma immunotherapy awarded close to €10M in the fifth call for Hospital-University Research in Health (RHU) projects
Spartha Medical receives €2.4M in financing from European Innovation Council
Spartha Medical receives €2.4M in financing from EIC
Biomunex Pharmaceutical’s breakthrough immunotherapy project receives grants close to €3 Million
Led by Biomunex alongside Institut Curie and GTP Bioways, with a total budget of €5.6 million, BiXAb5 non-conventional T cell redirection project seeks to create breakthrough immunotherapy approach to cancer treatment based on bispecific antibodies